Display Settings:

Format

Send to:

Choose Destination
    Pathol Oncol Res. 2008 Mar;14(1):79-83. Epub 2008 Mar 18.

    The diagnostic value of macrophage migration inhibitory factor (MIF) in gastric cancer.

    Source

    Preventive Oncology, Biostatistics and Epidemiology, Institute of Oncology, University of Istanbul, Capa, 34390 Istanbul, Turkey. hcamlica@istanbul.edu.tr

    Abstract

    The present study was conducted to investigate the sensitivity, specificity, predictive values and accuracy of serum MIF, CEA, CA 19-9 levels and their various combinations in patients with gastric cancer. Study group consists of pathologically verified, gastric cancer (n = 63) and apparently healthy controls (n = 50). Serum MIF concentrations were determined by enzyme-linked immunosorbent assay (ELISA). Serum values of patients were significantly higher than the controls (p = 0.011). Diagnostic sensitivity and specificity, predictive values and accuracies were calculated for each marker and their various combinations. The best results were achieved with the marker combination of MIF-CEA-CA 19-9 and MIF-CEA combination. In our opinion, the combination of the markers MIF-CEA is a valuable diagnostic tool for gastric cancer.

    PMID:
    18347935
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Springer

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk